Fuminori Sakai

1.1k citations
65 papers · 773 indexed · h-index 17
Topics
Pneumonia and Respiratory Infections (12 papers)Bacterial Infections and Vaccines (8 papers)Respiratory viral infections research (7 papers)

In The Last Decade

Fuminori Sakai

58 papers receiving 708 citations

Peers

Fuminori Sakai
Comparison fields: 5 of 93
  • Molecular Biology 259
  • Epidemiology 212
  • Infectious Diseases 110
  • Microbiology 109
  • Public Health, Environmental and Occupational Health 84
Replace R B Clark with:
R B Clark United States
Nannan Wu China
L Bertók Hungary
Myeongjin Choi South Korea
F. K. Hamra United States
Manuel Macías Spain
Frederick Verbeke Belgium
Ayan Mondal United States
Haihong Fang China
Luis Alberto Vega United States
Fuminori Sakai relative to R B Clark United States R B Clark's profile →
Citations per field
00.5×
R B Clark · 1×
Citations per year

Countries citing papers authored by Fuminori Sakai

Since Specialization
Citations

This map shows the geographic impact of Fuminori Sakai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fuminori Sakai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fuminori Sakai more than expected).

Fields of papers citing papers by Fuminori Sakai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fuminori Sakai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fuminori Sakai. The network helps show where Fuminori Sakai may publish in the future.

Co-authorship network of co-authors of Fuminori Sakai

This figure shows the co-authorship network connecting the top 25 collaborators of Fuminori Sakai. A scholar is included among the top collaborators of Fuminori Sakai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fuminori Sakai. Fuminori Sakai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 16
3 12
4 15
5 13
6 28
7 34
8 3
9 38
10 33
11 18
12 3
13
9
14 0
15 20
16 12
17 21
18 4
19 8
20 17

About Fuminori Sakai

Fuminori Sakai is a scholar working on Microbiology, Biochemistry and Clinical Biochemistry, having authored 65 papers that have together received 773 indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (12 papers), Bacterial Infections and Vaccines (8 papers) and Respiratory viral infections research (7 papers). The work is most often cited by research in Microbiology (109 citations), Clinical Biochemistry (79 citations) and Nephrology (55 citations). Fuminori Sakai has collaborated with scholars based in Japan, United States and Australia. Frequent co-authors include Hitoshi Endou, Jorge E. Vidal, Keith P. Klugman, Takeshi Hoshi, Hajime Shimada, Kimio Tomita, Chizuko Koseki, Tatsuo Suda, Takashi Akiba and Noboru Horiuchi. Their work appears in journals such as Nature, PLoS ONE and Applied and Environmental Microbiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026